These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36633771)

  • 21. Bcl2l10 induces metabolic alterations in ovarian cancer cells by regulating the TCA cycle enzymes SDHD and IDH1.
    Lee SY; Kwon J; Lee KA
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IDH1 gene mutation activates Smad signaling molecules to regulate the expression levels of cell cycle and biological rhythm genes in human glioma U87‑MG cells.
    Gao Y; Wu Y; Zhang N; Yuan H; Wang F; Xu H; Yu J; Ma J; Hou S; Cao X
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IDH1 Mutation Induces HIF-1
    Hu X; Li L; Eid JE; Liu C; Yu J; Yue J; Trent JC
    Dis Markers; 2022; 2022():7729968. PubMed ID: 35198082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterozygous IDH1
    Wei S; Wang J; Oyinlade O; Ma D; Wang S; Kratz L; Lal B; Xu Q; Liu S; Shah SR; Zhang H; Li Y; Quiñones-Hinojosa A; Zhu H; Huang ZY; Cheng L; Qian J; Xia S
    Oncogene; 2018 Sep; 37(38):5160-5174. PubMed ID: 29849122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism.
    Izquierdo-Garcia JL; Viswanath P; Eriksson P; Cai L; Radoul M; Chaumeil MM; Blough M; Luchman HA; Weiss S; Cairncross JG; Phillips JJ; Pieper RO; Ronen SM
    Cancer Res; 2015 Aug; 75(15):2999-3009. PubMed ID: 26045167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic and oncogenic adaptations to pyruvate dehydrogenase inactivation in fibroblasts.
    Wang H; Lu J; Kulkarni S; Zhang W; Gorka JE; Mandel JA; Goetzman ES; Prochownik EV
    J Biol Chem; 2019 Apr; 294(14):5466-5486. PubMed ID: 30755479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction between IDH1 WT and calmodulin and its implications for glioblastoma cell growth and migration.
    Kang S; Kwon HN; Kang S; Park S
    Biochem Biophys Res Commun; 2020 Mar; 524(1):224-230. PubMed ID: 31983428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation.
    Li S; Chou AP; Chen W; Chen R; Deng Y; Phillips HS; Selfridge J; Zurayk M; Lou JJ; Everson RG; Wu KC; Faull KF; Cloughesy T; Liau LM; Lai A
    Neuro Oncol; 2013 Jan; 15(1):57-68. PubMed ID: 23115158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolomic comparison between cells over-expressing isocitrate dehydrogenase 1 and 2 mutants and the effects of an inhibitor on the metabolism.
    Wen H; Cho HR; Yun T; Kim H; Park CK; Lee SH; Choi SH; Park S
    J Neurochem; 2015 Jan; 132(2):183-93. PubMed ID: 25251602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Idh1 protects murine hepatocytes from endotoxin-induced oxidative stress by regulating the intracellular NADP(+)/NADPH ratio.
    Itsumi M; Inoue S; Elia AJ; Murakami K; Sasaki M; Lind EF; Brenner D; Harris IS; Chio II; Afzal S; Cairns RA; Cescon DW; Elford AR; Ye J; Lang PA; Li WY; Wakeham A; Duncan GS; Haight J; You-Ten A; Snow B; Yamamoto K; Ohashi PS; Mak TW
    Cell Death Differ; 2015 Nov; 22(11):1837-45. PubMed ID: 25882048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lactate dehydrogenase A silencing in IDH mutant gliomas.
    Chesnelong C; Chaumeil MM; Blough MD; Al-Najjar M; Stechishin OD; Chan JA; Pieper RO; Ronen SM; Weiss S; Luchman HA; Cairncross JG
    Neuro Oncol; 2014 May; 16(5):686-95. PubMed ID: 24366912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IDH1 mutation activates mTOR signaling pathway, promotes cell proliferation and invasion in glioma cells.
    Avsar T; Kose TB; Oksal MD; Turan G; Kilic T
    Mol Biol Rep; 2022 Oct; 49(10):9241-9249. PubMed ID: 35934766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism.
    Rendina AR; Pietrak B; Smallwood A; Zhao H; Qi H; Quinn C; Adams ND; Concha N; Duraiswami C; Thrall SH; Sweitzer S; Schwartz B
    Biochemistry; 2013 Jul; 52(26):4563-77. PubMed ID: 23731180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiolipin-induced activation of pyruvate dehydrogenase links mitochondrial lipid biosynthesis to TCA cycle function.
    Li Y; Lou W; Raja V; Denis S; Yu W; Schmidtke MW; Reynolds CA; Schlame M; Houtkooper RH; Greenberg ML
    J Biol Chem; 2019 Jul; 294(30):11568-11578. PubMed ID: 31186346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isocitrate dehydrogenases 2-mediated dysfunctional metabolic reprogramming promotes intestinal cancer progression via regulating HIF-1A signaling pathway.
    Liu S; Zhou Y; Chen Y; Qiao Y; Bai L; Zhang S; Men D; Zhang H; Pan F; Gao Y; Wang J; Wang Y
    Int Immunopharmacol; 2024 Oct; 140():112828. PubMed ID: 39094359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of evidence for substrate channeling or flux between wildtype and mutant isocitrate dehydrogenase to produce the oncometabolite 2-hydroxyglutarate.
    Dexter JP; Ward PS; Dasgupta T; Hosios AM; Gunawardena J; Vander Heiden MG
    J Biol Chem; 2018 Dec; 293(52):20051-20061. PubMed ID: 30381394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutant IDH1 promotes phagocytic function of microglia/macrophages in gliomas by downregulating ICAM1.
    Ma D; Zhan D; Fu Y; Wei S; Lal B; Wang J; Li Y; Lopez-Bertoni H; Yalcin F; Dzaye O; Eberhart CG; Laterra J; Wilson MA; Ying M; Xia S
    Cancer Lett; 2021 Oct; 517():35-45. PubMed ID: 34098063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventing pyruvate kinase muscle expression in Chinese hamster ovary cells curbs lactogenic behavior by altering glycolysis, gating pyruvate generation, and increasing pyruvate flux into the TCA cycle.
    Tang D; Sandoval W; Liu P; Lam C; Snedecor B; Misaghi S
    Biotechnol Prog; 2021 Sep; 37(5):e3193. PubMed ID: 34288605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting cancer metabolism.
    Teicher BA; Linehan WM; Helman LJ
    Clin Cancer Res; 2012 Oct; 18(20):5537-45. PubMed ID: 23071355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. R132H mutation in IDH1 gene reduces proliferation, cell survival and invasion of human glioma by downregulating Wnt/β-catenin signaling.
    Cui D; Ren J; Shi J; Feng L; Wang K; Zeng T; Jin Y; Gao L
    Int J Biochem Cell Biol; 2016 Apr; 73():72-81. PubMed ID: 26860959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.